<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="//www.ivybraintumorcenter.org/es/wp-content/plugins/wordpress-seo/css/main-sitemap.xsl"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-image/1.1 http://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
	<url>
		<loc>https://www.ivybraintumorcenter.org/es/resource/</loc>
		<lastmod>2022-06-09T16:37:02+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.ivybraintumorcenter.org/es/resource/estrategias-de-ensayos-clinicos-de-fase-0-para-el-neurocirujano-oncologo/</loc>
		<lastmod>2022-06-09T16:28:21+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.ivybraintumorcenter.org/es/resource/un-ensayo-de-fase-0-de-ribociblib-en-pacientes-con-glioblastoma-recurrente-incorporando-una-cohorte-de-expansion-tumoral-guiada-por-farmacodinamica-y-farmacocinetica/</loc>
		<lastmod>2022-06-09T16:29:18+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.ivybraintumorcenter.org/es/resource/ensayo-de-fase-0-de-azd1775-en-pacientes-con-glioblastoma-de-primera-recurrencia/</loc>
		<lastmod>2022-06-09T16:30:35+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.ivybraintumorcenter.org/es/resource/un-metodo-de-cromatografia-de-liquidos-con-espectrometria-de-masas-en-tandem-para-cuantificar-el-ceritinib-total-y-no-unido-en-el-plasma-y-tumor-cerebral-del-paciente/</loc>
		<lastmod>2022-06-09T16:31:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.ivybraintumorcenter.org/es/resource/comprension-cuantitativa-y-mecanica-de-la-penetracion-de-azd1775-a-traves-de-la-barrera-hematoencefalica-en-pacientes-con-glioblastoma-utilizando-un-enfoque-ivive-junto-con-modelado-pbpk/</loc>
		<lastmod>2022-06-09T16:32:44+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.ivybraintumorcenter.org/es/resource/un-ensayo-desencadenante-de-fase-0-de-inhibidores-de-cdk4-6-mas-erk1-2-en-glioblastoma-recurrente/</loc>
		<lastmod>2022-06-09T16:33:32+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.ivybraintumorcenter.org/es/resource/terapia-sonodinamica-con-acido-5-aminolevulinico-en-glioblastoma-recurrente-primer-ensayo-clinico-de-fase-0-1-en-humanos/</loc>
		<lastmod>2022-06-09T16:35:51+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.ivybraintumorcenter.org/es/resource/un-ensayo-desencadenante-de-fase-0-1-de-ribociclib-mas-everolimus-en-glioma-recurrente-de-alto-grado/</loc>
		<lastmod>2022-06-09T16:36:34+00:00</lastmod>
	</url>
	<url>
		<loc>https://www.ivybraintumorcenter.org/es/resource/funciones-especificas-de-isoforma-no-redundantes-de-hdac1-en-celulas-madre-de-glioma/</loc>
		<lastmod>2022-06-09T16:37:02+00:00</lastmod>
	</url>
</urlset>
<!-- XML Sitemap generated by Yoast SEO -->